Latest Insider Transactions at Danaher Corp (DHR)
This section provides a real-time view of insider transactions for Danaher Corp (DHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DANAHER CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DANAHER CORP 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Christopher Bouda VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
978
+11.48%
|
-
|
|
Feb 26
2024
|
Christopher Bouda VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-4.84%
|
$84,502
$253.84 P/Share
|
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
SELL
Open market or private sale
|
Direct |
23,757
-38.41%
|
$5,986,764
$252.0 P/Share
|
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
23,757
+27.75%
|
$1,377,906
$58.48 P/Share
|
|
Feb 26
2024
|
Daniel Raskas SVP - Corporate Development |
SELL
Bona fide gift
|
Direct |
591
-1.53%
|
-
|
|
Feb 26
2024
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
866
-7.95%
|
$219,098
$253.84 P/Share
|
|
Feb 26
2024
|
Christopher Paul Riley Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
539
-3.49%
|
$136,367
$253.84 P/Share
|
|
Feb 26
2024
|
Georgeann Couchara SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
265
-6.24%
|
$67,045
$253.84 P/Share
|
|
Feb 21
2024
|
Joakim Weidemanis Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
7,880
+8.1%
|
-
|
|
Feb 21
2024
|
Christopher Paul Riley Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
2,367
+13.29%
|
-
|
|
Feb 21
2024
|
Matthew Mc Grew EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,911
+10.46%
|
-
|
|
Feb 21
2024
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,155
+22.46%
|
-
|
|
Feb 21
2024
|
Daniel Raskas SVP - Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+8.23%
|
-
|
|
Feb 21
2024
|
Brian W Ellis Senior Vice President - GC |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+10.44%
|
-
|
|
Feb 21
2024
|
William King SVP, Strategic Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+7.54%
|
-
|
|
Feb 21
2024
|
Rainer Blair President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,698
+13.61%
|
-
|
|
Feb 15
2024
|
Walter G Lohr Director |
SELL
Open market or private sale
|
Direct |
3,289
-18.88%
|
$825,539
$251.15 P/Share
|
|
Feb 15
2024
|
Walter G Lohr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,289
+15.88%
|
$171,028
$52.56 P/Share
|
|
Feb 13
2024
|
Georgeann Couchara SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
2,622
-23.06%
|
$634,524
$242.67 P/Share
|
|
Feb 13
2024
|
Georgeann Couchara SVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,622
+18.51%
|
$175,674
$67.53 P/Share
|
|
Feb 06
2024
|
Teri List Director |
SELL
Open market or private sale
|
Direct |
3,289
-14.29%
|
$815,672
$248.32 P/Share
|
|
Feb 06
2024
|
Teri List Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,289
+12.5%
|
$171,028
$52.56 P/Share
|
|
Feb 01
2024
|
Daniel Raskas SVP - Corporate Development |
SELL
Payment of exercise price or tax liability
|
Direct |
5,984
-14.52%
|
$1,466,080
$245.13 P/Share
|
|
Feb 01
2024
|
Joakim Weidemanis Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
16,588
-16.9%
|
$4,064,060
$245.13 P/Share
|
|
Feb 01
2024
|
Brian W Ellis Senior Vice President - GC |
SELL
Payment of exercise price or tax liability
|
Direct |
7,634
-20.35%
|
$1,870,330
$245.13 P/Share
|
|
Feb 01
2024
|
Rainer Blair President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
19,107
-15.36%
|
$4,681,215
$245.13 P/Share
|
|
Feb 01
2024
|
Matthew Mc Grew EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,785
-19.44%
|
$2,642,325
$245.13 P/Share
|
|
Feb 01
2024
|
William King SVP, Strategic Development |
SELL
Payment of exercise price or tax liability
|
Direct |
5,525
-12.38%
|
$1,353,625
$245.13 P/Share
|
|
Aug 21
2023
|
Jose Carlos Gutierrez Ramos SVP, Chief Science Officer |
SELL
Open market or private sale
|
Direct |
590
-7.84%
|
$147,500
$250.54 P/Share
|
|
Jul 28
2023
|
Linda Filler Director |
SELL
Open market or private sale
|
Direct |
10,190
-11.56%
|
$2,649,400
$260.26 P/Share
|
|
Jul 28
2023
|
Linda Filler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,922
+6.64%
|
$172,398
$59.17 P/Share
|
|
Jul 28
2023
|
John T Schwieters Director |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-3.02%
|
$177,320
$260.07 P/Share
|
|
Jul 28
2023
|
John T Schwieters Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,490
+13.39%
|
$174,500
$50.8 P/Share
|
|
Jul 28
2023
|
Elias A. Zerhouni Director |
SELL
Payment of exercise price or tax liability
|
Direct |
682
-2.23%
|
$177,320
$260.07 P/Share
|
|
Jul 28
2023
|
Elias A. Zerhouni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,490
+10.26%
|
$174,500
$50.8 P/Share
|
|
Jul 28
2023
|
Daniel Raskas SVP - Corporate Development |
SELL
Open market or private sale
|
Direct |
11,213
-22.65%
|
$2,915,380
$260.65 P/Share
|
|
Jul 28
2023
|
Daniel Raskas SVP - Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,213
+18.47%
|
$627,928
$56.7 P/Share
|
|
Jul 28
2023
|
Daniel Raskas SVP - Corporate Development |
SELL
Bona fide gift
|
Direct |
385
-1.0%
|
-
|
|
Jul 26
2023
|
Teri List Director |
SELL
Open market or private sale
|
Direct |
3,490
-16.63%
|
$917,870
$263.3 P/Share
|
|
Jul 26
2023
|
Teri List Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,490
+14.26%
|
$174,500
$50.8 P/Share
|
|
Jul 26
2023
|
Joakim Weidemanis Executive Vice President |
SELL
Open market or private sale
|
Direct |
22,439
-20.19%
|
$5,901,457
$263.42 P/Share
|
|
Jul 26
2023
|
Joakim Weidemanis Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,439
+16.8%
|
$1,256,584
$56.7 P/Share
|
|
Jul 17
2023
|
Christopher Bouda VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-0.82%
|
$12,960
$240.53 P/Share
|
|
May 31
2023
|
Daniel Raskas SVP - Corporate Development |
SELL
Open market or private sale
|
Direct |
19,847
-33.91%
|
$4,525,116
$228.5 P/Share
|
|
May 31
2023
|
Daniel Raskas SVP - Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
19,847
+25.33%
|
$1,131,279
$57.9 P/Share
|
|
May 15
2023
|
Joakim Weidemanis Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,734
-2.99%
|
$617,884
$226.94 P/Share
|
|
May 15
2023
|
Jennifer Honeycutt Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
186
-0.71%
|
$42,036
$226.94 P/Share
|
|
May 15
2023
|
Alan G Spoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+0.4%
|
-
|
|
May 15
2023
|
Raymond C Stevens Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+4.52%
|
-
|
|
May 15
2023
|
Elias A. Zerhouni Director |
BUY
Grant, award, or other acquisition
|
Direct |
430
+1.57%
|
-
|